.png "WellCare Health Plans (NYSE: WCG)")
In a report released yesterday, Steven Valiquette from Barclays maintained a Buy rating on WellCare Health Plans (NYSE: WCG), with a price target of $325. The company’s shares closed yesterday at $300.81, close to its 52-week high of $315.65.
According to TipRanks.com, Valiquette is a 4-star analyst with an average return of 9.0% and a 54.1% success rate. Valiquette covers the Services sector, focusing on stocks such as Patterson Companies Inc, Molina Healthcare, and Community Health.
WellCare Health Plans has an analyst consensus of Strong Buy, with a price target consensus of $312, representing a 3.7% upside. In a report issued on September 7, SunTrust Robinson also maintained a Buy rating on the stock with a $360 price target.
.
See today’s analyst top recommended stocks >>
WellCare Health Plans’ market cap is currently $13.47B and has a P/E ratio of 27.96. The company has a Price to Book ratio of 5.04.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
WellCare Health Plans, Inc. engages in the provision of government-sponsored managed care services through Medicaid, Medicare Advantage, and Medicare Prescription Drug Plans to families, children, seniors, and individuals with complex medical needs. It operates through the following segments: Medicaid Health Plans, Medicare Health Plans, and Medicare PDPs.
